To optimally uncover potential differences MDR-Mtb V791 infection and TB lesions between adjunctive ZOL/IL-2 or IL-2 and controls, each macaques in four studied groups were injected subcutaneously with Adalimumab during the last 4 weeks before the endpoint [13]. Here, IL2 is linked to tuberculosis.